subject: UMLS:C0034790


subject: CHEBI:5280

subject_name: Gatifloxacin

object_name: Bacterial keratitis

tested_intervention: yes


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: B-cell non-Hodgkin lymphoma

tested_intervention: unsure


subject: UNII:PVI5M0M1GW

object_name: B-cell neoplasm


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: UMLS:C0879272


subject: UMLS:C2703124

object_name: non-small cell lung carcinoma


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Fused vertebrae


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: adult hepatocellular carcinoma


subject: CHEBI:72317

object_name: liver cancer


subject: CHEBI:72317

object_name: pediatric hepatocellular carcinoma


subject: UMLS:C0308804

subject_name: Dexamethasone Sodium Phosphate Injection

object_name: Post-Operative Pain


subject: UMLS:C5203471

subject_name: Dexmedetomidine Liquid Injection


subject: PUBCHEM.COMPOUND:76470875

subject_name: Glecaprevir

object_name: post-traumatic stress disorder


subject: PUBCHEM.COMPOUND:76470875

object_name: BH4-deficient hyperphenylalaninemia A


subject: UMLS:C1314412

subject_name: INJECTION, ALEFACEPT, 0.5 MG ADMINISTERED

object_name: psoriasis


subject: UNII:ELK3V90G6C

subject_name: Alefacept


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage I Renal Cell Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage I Renal Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage II Renal Cell Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage II Renal Cell Cancer


subject: UNII:2S9ZZM9Q9V

object_name: Stage II Renal Cell Cancer AJCC v7


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:38940


subject: CHEBI:38940


subject: UMLS:C3886709

subject_name: actiponin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C3886709

object_name: obesity


subject: UMLS:C3886709

object_name: Obesity, CTCAE


subject: UMLS:C0016004

subject_name: Beriplast P

object_name: Hernia of the abdominal wall


subject: UMLS:C0016004

object_name: Hernia


subject: UMLS:C0016004

object_name: Ventral hernia


subject: UMLS:C4482906

subject_name: Imipenem+Relebactam

object_name: Sepsis


subject: UMLS:C4482906

object_name: Sepsis, CTCAE


subject: HMDB:HMDB0256702

subject_name: Porfimer Sodium

object_name: carcinoma of esophagus


subject: HMDB:HMDB0256702

object_name: esophageal cancer


subject: HMDB:HMDB0256702

object_name: Childhood Esophageal Carcinoma


subject: HMDB:HMDB0256702

object_name: neoplasm of esophagus


subject: UNII:Y3834SIK5F

subject_name: PORFIMER SODIUM


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: UNII:Y3834SIK5F


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: influenza A


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine


subject: UNII:J4L83T8MZ5

subject_name: ECHINOCHROME A

object_name: long COVID-19


subject: CHEBI:63450

subject_name: Masitinib

object_name: mastocytosis


subject: UMLS:C2351399


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Langerhans cell histiocytosis


subject: PUBCHEM.COMPOUND:596

object_name: Langerhans cell histiocytosis specific to childhood


subject: PUBCHEM.COMPOUND:596

object_name: Langerhans cell histiocytosis specific to adulthood


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Stomach cancer


subject: CHEBI:28918

object_name: gastric cancer


subject: CHEBI:28918


subject: CHEBI:28918


subject: CHEBI:28918


subject: CHEBI:28918


subject: PR:000016279

subject_name: tissue factor pathway inhibitor


subject: PR:000016279


subject: PR:000016279


subject: PR:000016279


subject: PR:000016279


subject: PR:000016279


subject: CHEBI:30145

subject_name: lithium atom

object_name: bipolar depression


subject: CHEBI:30145

object_name: major depressive episode


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: UNII:L2N7Z24B30


subject: CHEBI:49713

subject_name: Lithium cation


subject: CHEBI:49713


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: UMLS:C3540800


subject: UNII:W7O69J5F2B

subject_name: Cyclo(prolylglycyl)

object_name: Cognitive impairment


subject: UNII:W7O69J5F2B

object_name: mild neurocognitive disorder


subject: UNII:W7O69J5F2B

object_name: mild cognitive impairment


subject: UNII:W7O69J5F2B

object_name: Alzheimer disease type 1


subject: UNII:W7O69J5F2B

object_name: Alzheimer disease


subject: UNII:W7O69J5F2B

object_name: cognitive disorder


subject: UNII:W7O69J5F2B

object_name: neurodegenerative disease


subject: UNII:W7O69J5F2B

object_name: Lewy Bodies


subject: UNII:W7O69J5F2B

object_name: vascular dementia


subject: UNII:W7O69J5F2B

object_name: tauopathy


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: immune system disorder


subject: UMLS:C0910794


subject: DRUGBANK:DB17293

subject_name: Hiltonol

object_name: Brain Stem Glioblastoma


subject: DRUGBANK:DB17293

object_name: glioma susceptibility 1


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:7KYP9TKT70


subject: CHEBI:231324

subject_name: alpelisib

object_name: esophageal squamous cell carcinoma


subject: UMLS:C2986399


subject: UMLS:C5960018

subject_name: Pan-DDR DNA Decoy-cholesterol Conjugate VIO-01

object_name: Recurrent ovarian cancer


subject: UMLS:C5960018

object_name: prostate carcinoma


subject: UMLS:C5960018

object_name: prostate cancer


subject: UMLS:C5960018

object_name: Childhood Breast Carcinoma


subject: UMLS:C5960018

object_name: breast carcinoma


subject: UMLS:C5960018

object_name: breast cancer


subject: CHEBI:8774

subject_name: Ramipril

object_name: Heart failure with reduced ejection fraction


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: Acute radiation enteritis of intestine


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:177762

subject_name: Alovudine

object_name: non-small cell lung carcinoma


subject: PR:000007563

subject_name: vascular endothelial growth factor receptor 1


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)


subject: CHEBI:90001

subject_name: cystathionine ketimine


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: PR:000050337

subject_name: mature calcitonin


subject: UMLS:C4329442

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: UMLS:C5703306

subject_name: Saposin C


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: leukemia


subject: PUBCHEM.COMPOUND:73005958

object_name: childhood leukemia


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C4287690

subject_name: BET Bromodomain Inhibitor ZEN-3694

object_name: squamous cell lung carcinoma


subject: CHEBI:53774

subject_name: tergitol

object_name: HIV infection


subject: CHEBI:53775


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: skin neoplasm


subject: PUBCHEM.COMPOUND:70789204

object_name: skin cancer


subject: CHEBI:50378

subject_name: Nitisinone

object_name: alkaptonuria


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Metastatic Salivary Gland Carcinoma


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:95021

object_name: Stage IV Major Salivary Gland Cancer AJCC v8


subject: CHEBI:95021

object_name: adrenal cortex carcinoma


subject: CHEBI:95021

object_name: adenoid cystic carcinoma


subject: UMLS:C5854645

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UMLS:C5854645

object_name: metastatic neoplasm


subject: UMLS:C5854645

object_name: Embolism, Tumor


subject: UMLS:C5854645

object_name: Neoplasm Metastasis


subject: UMLS:C5854645

object_name: colorectal adenocarcinoma


subject: CHEBI:6801

subject_name: Metformin

object_name: Insulin Sensitivity


subject: HMDB:HMDB0033369

subject_name: Hydroxypropyl methylcellulose

object_name: Acanthamoeba keratitis


subject: CHEBI:30618

subject_name: hydroxypropyl methylcellulose


subject: UNII:B1QE5P712K

subject_name: hypromellose 2208 (100 MPA.S)


subject: CHEBI:185135

subject_name: Polyvidone


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: CHEBI:8378

subject_name: Prednisolone


subject: PUBCHEM.COMPOUND:164532637

object_name: Hepatic impairment


subject: CHEBI:27300

subject_name: Ergocalciferol

object_name: Homocystinemia


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C2713028

subject_name: ABI 009

object_name: neuroendocrine neoplasm


subject: CHEBI:47458

subject_name: Saracatinib


subject: CHEBI:47458

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:47458

object_name: Malignant neoplasm of stomach stage III


subject: CHEBI:47458

object_name: recurrent gastric cancer


subject: CHEBI:47458

object_name: gastric adenocarcinoma


subject: CHEBI:47458

object_name: Stage IV Esophageal Cancer AJCC v6


subject: CHEBI:47458

object_name: Stage IV Esophageal Cancer AJCC v7


subject: CHEBI:47458

object_name: stage IV esophageal cancer


subject: CHEBI:47458

object_name: Stage III Esophageal Cancer AJCC v7


subject: CHEBI:47458

object_name: Stage III Esophageal Cancer


subject: CHEBI:95341

subject_name: Baricitinib

object_name: systemic sclerosis


subject: UMLS:C5565375

object_name: endometriosis


subject: UNII:DPT0O3T46P

object_name: Malignant neoplasm of female breast


subject: UNII:DPT0O3T46P

object_name: Stage IIIC Colorectal Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IIIA Colorectal Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IIIB Colorectal Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Refractory Colorectal Adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: Microsatellite Stable


subject: PUBCHEM.COMPOUND:135537060

subject_name: Rintatolimod

object_name: Unresectable Colorectal Carcinoma


subject: PUBCHEM.COMPOUND:135537060

object_name: Metastatic Colorectal Adenocarcinoma


subject: PUBCHEM.COMPOUND:135537060


subject: PUBCHEM.COMPOUND:135537060

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Stage IV Colorectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Stage III Colorectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060


subject: PUBCHEM.COMPOUND:135537060


subject: PUBCHEM.COMPOUND:135537060


subject: PUBCHEM.COMPOUND:135537060


subject: PUBCHEM.COMPOUND:135537060

object_name: Mismatch Repair Proficient


subject: UNII:94325AJ25N

subject_name: RINTATOLIMOD


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: UNII:94325AJ25N


subject: UMLS:C0935953

subject_name: Mobist

object_name: ocular melanoma


subject: UMLS:C0935953

object_name: uveal melanoma


subject: UMLS:C0935953

object_name: mucosal melanoma


subject: UMLS:C0935953

object_name: skin melanoma


subject: UMLS:C0935953

object_name: Melanoma of Unknown Primary


subject: UMLS:C0935953

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: UMLS:C0935953

object_name: Stage III Cutaneous Melanoma AJCC v7


subject: UMLS:C0935953

object_name: Stage IIIA Cutaneous Melanoma AJCC v7


subject: UMLS:C0935953

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: UMLS:C0935953

object_name: Stage IIB Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C0935953

object_name: Stage IIC Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C0935953

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:59495

subject_name: CIDOFOVIR

object_name: papilloma


subject: CHEBI:530615


subject: CHEBI:134514


subject: CHEBI:3696

subject_name: Cidofovir


subject: CHEBI:167309

subject_name: Methadone

object_name: cancer


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: Unexplained infertility


subject: CHEBI:95021

subject_name: pemetrexed

object_name: Carcinoma breast stage IV


subject: CHEBI:95021

object_name: Breast cancer recurrent


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:125427

object_name: non-small cell lung carcinoma


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:94793

subject_name: Pimasertib

object_name: liver carcinoma


subject: UMLS:C1541478

subject_name: Astuprotimut-R

object_name: plasma cell myeloma


subject: CHEBI:30797

subject_name: (S)-malic acid

object_name: Xerostomia


subject: CHEBI:6650

subject_name: Malic acid


subject: CHEBI:49134

object_name: neoplasm


subject: CHEBI:49134

object_name: adverse effect


subject: CHEBI:49134

object_name: pulmonary coin lesion


subject: CHEBI:8673

subject_name: Pyrimethamine

object_name: Plasmodium falciparum malaria


subject: UMLS:C1579314

subject_name: Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed

object_name: poliomyelitis


subject: UMLS:C1579314

object_name: pertussis


subject: UMLS:C1579314

object_name: diphtheria


subject: UMLS:C3526553

subject_name: diphtheria, tetanus toxoids and acellular pertussis vaccine


subject: PR:000023565

subject_name: DNA polymerase I


subject: PR:000023565


subject: PR:000023565


subject: UMLS:C0035678

subject_name: RNA Polymerase I


subject: UMLS:C0035678


subject: UMLS:C0035678


subject: UNII:K65KST652D

object_name: Advanced cancer


subject: UMLS:C3896897

subject_name: Anti-mesothelin Antibody-drug Conjugate BMS-986148


subject: CHEBI:31822

subject_name: MERCAPTOPURINE

object_name: ulcerative colitis


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: UMLS:C0722911

subject_name: Purinethol


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: alcohol dependence


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879

object_name: post-traumatic stress disorder


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: CHEBI:74815

subject_name: Ser-Leu


subject: CHEBI:74815


subject: GTOPDB:11346

subject_name: vilobelimab

object_name: pyoderma gangrenosum


subject: UNII:F5T0RF9ZJA


subject: UMLS:C5392705


subject: UNII:T4H8FMA7IM

subject_name: Siltuximab

object_name: T-cell large granular lymphocyte leukemia


subject: UMLS:C0528358

object_name: end stage renal failure


subject: UMLS:C0528358

object_name: Chronic uremia


subject: CHEBI:41879

object_name: Implant Capsular Contracture


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: castration-resistant prostate carcinoma


subject: CHEBI:64310

subject_name: Crizotinib


subject: UNII:9628AJ27JA

subject_name: Presatovir

object_name: respiratory syncytial virus infectious disease


subject: PUBCHEM.COMPOUND:122316

object_name: Restless legs


subject: CHEBI:63620

subject_name: Rasagiline


subject: CHEBI:6015

subject_name: Isoflurane


subject: CHEBI:6015

object_name: Hypoxic respiratory failure


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Stage IV adult soft tissue sarcoma


subject: CHEBI:52717

object_name: stage III adult soft tissue sarcoma


subject: CHEBI:52717

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:45716


subject: CHEBI:45716


subject: PUBCHEM.COMPOUND:3367

object_name: Acute lymphoid leukemia in remission


subject: PUBCHEM.COMPOUND:3367

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:3367

object_name: Acute myeloid leukemia in remission


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: periapical tissue disease


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:39867

subject_name: Valproic acid

object_name: Adult Solid Neoplasm


subject: CHEBI:61397

subject_name: Neratinib


subject: CHEBI:177298

object_name: central nervous system cancer


subject: CHEBI:177298

object_name: Malignant neoplasm of the central nervous system


subject: CHEBI:177298

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:177298

object_name: Embolism, Tumor


subject: CHEBI:177298

object_name: Neoplasm Metastasis


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:231679

subject_name: ipilimumab

object_name: gastroesophageal cancer


subject: GTOPDB:1160

subject_name: hCG

object_name: Pregnancy Outcome


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: CHEBI:66919

object_name: vitiligo


subject: UMLS:C5210526

subject_name: ProAir Digihaler

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C5210526

object_name: COPD, severe early onset


subject: UMLS:C5210526

object_name: chronic obstructive pulmonary disease


subject: UMLS:C5210526

object_name: Acute exacerbation of chronic obstructive pulmonary disease


subject: DRUGBANK:DB14248

subject_name: Bos taurus gallstone

object_name: acute disseminated encephalomyelitis


subject: DRUGBANK:DB14248

object_name: neuromyelitis optica


subject: DRUGBANK:DB14248

object_name: multiple sclerosis


subject: DRUGBANK:DB14248

object_name: myelin oligodendrocyte glycoprotein antibody-associated disease


subject: PUBCHEM.COMPOUND:22833609

subject_name: Chitobiose


subject: PUBCHEM.COMPOUND:22833609


subject: PUBCHEM.COMPOUND:22833609


subject: PUBCHEM.COMPOUND:22833609


subject: CHEBI:86158

subject_name: calcium chloride dihydrate

object_name: basal cell carcinoma


subject: CHEBI:86158

object_name: skin basal cell carcinoma


subject: CHEBI:3312

subject_name: Calol


subject: CHEBI:3312


subject: CHEBI:61049

subject_name: Tacrolimus

object_name: lymphedema


subject: CHEBI:61049

object_name: Lymphedema, CTCAE


subject: UMLS:C1567931

subject_name: Macugen

object_name: proliferative diabetic retinopathy


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: Refractory acute myeloid leukemia


subject: UMLS:C4086713

object_name: Neoplasm, Residual


subject: UMLS:C4086713

object_name: Myelodysplasia


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: GTOPDB:12652

subject_name: magrolimab

object_name: Childhood Solid Neoplasm


subject: GTOPDB:12652

object_name: Adult Solid Neoplasm


subject: GTOPDB:12652

object_name: Solid Neoplasm


subject: GTOPDB:12652

object_name: colorectal cancer


subject: GTOPDB:12652

object_name: colorectal carcinoma


subject: GTOPDB:12652

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: CHEBI:9123

subject_name: Sertraline

object_name: Maternity blues


subject: PR:000001345

subject_name: endoglin

object_name: Metastatic Hormone Receptor-Positive Breast Carcinoma


subject: PR:000001345

object_name: Metastatic HER2-Negative Breast Carcinoma


subject: PR:000017525

subject_name: Y-box-binding protein 1


subject: PR:000017525


subject: CHEBI:31348

subject_name: Capecitabine


subject: UMLS:C5781372

subject_name: Cyclin-Dependent Kinase 4 Inhibitor


subject: UMLS:C5781372


subject: UMLS:C5781372

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: PR:000005278

subject_name: cyclin-dependent kinase 4 inhibitor C


subject: PR:000005278


subject: PR:000005278


subject: UMLS:C5780984

subject_name: Cyclin-Dependent Kinase 6 Inhibitor


subject: UMLS:C5780984


subject: UMLS:C5780984


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: CHEBI:6121

subject_name: Ketamine

object_name: sickle cell-hemoglobin c disease syndrome


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: Glabellar frown lines


subject: UNII:NF3P9Z8J5Y

subject_name: baxdrostat

object_name: hypertension


subject: UNII:NF3P9Z8J5Y

object_name: Hypertension, CTCAE


subject: DRUGBANK:DB19090

subject_name: Baxdrostat


subject: DRUGBANK:DB19090


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: Locally Advanced Gastric Adenocarcinoma


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: CHEBI:6121

object_name: Dysesthesia


subject: CHEBI:6121

object_name: Inflammatory Response


subject: CHEMBL.COMPOUND:CHEMBL4297681

object_name: non-Hodgkin lymphoma


subject: UMLS:C0732644

subject_name: NovoNorm

object_name: type 2 diabetes mellitus


subject: CHEBI:91899

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:3207

subject_name: Budesonide


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: Secondary malignant neoplasm of lung


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: CHEBI:8231

subject_name: Pipecuronium bromide

object_name: Postoperative Residual Curarization


subject: CHEBI:174377

subject_name: Demethylvestitol


subject: CHEBI:8230

subject_name: Pipecuronium


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: endocrine system disorder


subject: CHEBI:7454

subject_name: Nalbuphine

object_name: acute respiratory distress syndrome


subject: CHEBI:7454

object_name: adult acute respiratory distress syndrome


subject: CHEBI:36796

subject_name: duloxetine

object_name: Low back pain


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)

object_name: Repeated implantation failure


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Feeding Intolerance


subject: UNII:PVI5M0M1GW

object_name: Feeding Intolerance, AE


subject: UNII:PVI5M0M1GW

object_name: perinatal necrotizing enterocolitis


subject: UNII:PVI5M0M1GW

object_name: necrotizing enterocolitis


subject: UNII:PVI5M0M1GW

object_name: Necrotizing Enterocolitis, AE


subject: GTOPDB:7995

subject_name: racotumomab

object_name: Childhood Neuroblastoma


subject: GTOPDB:7995

object_name: neuroblastoma


subject: UNII:52G405U1E5


subject: UNII:52G405U1E5


subject: UMLS:C2986854


subject: UMLS:C2986854


subject: CHEBI:31215

subject_name: anecortave

object_name: central retinal vein occlusion


subject: CHEBI:31215

object_name: Chronic inflammation


subject: CHEBI:31215

object_name: infectious disease


subject: GTOPDB:10656

subject_name: ianalumab

object_name: EXCESS LMW-DNA


subject: UNII:ZN2GQ3II96


subject: UMLS:C3896750


subject: UMLS:C1701110

subject_name: Zactima

object_name: lung cancer


subject: UMLS:C1701110

object_name: lung neoplasm


subject: UMLS:C1701110

object_name: lung carcinoma


subject: CHEBI:134723

subject_name: Asunaprevir

object_name: liver failure


subject: UMLS:C3491975


subject: UMLS:C2987379

object_name: cancer


subject: UMLS:C2987379

object_name: neoplasm


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UNII:D99YVK4L0X


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: CHEBI:50733

subject_name: nutraceutical

object_name: traumatic encephalopathy


subject: CHEBI:50733

object_name: traumatic brain injury


subject: MESH:C587735

subject_name: Oligopin


subject: MESH:C587735


subject: CHEBI:31348

subject_name: Capecitabine

object_name: anus cancer


subject: CHEBI:31348

object_name: anal carcinoma


subject: CHEBI:194095

subject_name: mitomycin C(1-)


subject: CHEBI:194095


subject: MESH:D011760

subject_name: Pyrrolidinones

object_name: Childhood Breast Carcinoma


subject: MESH:D011760

object_name: breast carcinoma


subject: MESH:D011760

object_name: breast cancer


subject: CHEBI:36592

subject_name: Pyrrolidone


subject: CHEBI:36592


subject: CHEBI:36592


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: differentiated thyroid carcinoma


subject: UMLS:C3827082


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: ovarian cancer


subject: CHEBI:72317

object_name: ovarian neoplasm


subject: CHEBI:72317

object_name: ovarian carcinoma


subject: CHEBI:72317

object_name: endometrial cancer


subject: CHEBI:72317

object_name: uterine corpus cancer


subject: CHEBI:72317

object_name: endometrial carcinoma


subject: CHEBI:72317

object_name: triple-negative breast carcinoma


subject: CHEBI:72317

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:72317

object_name: Stomach cancer


subject: CHEBI:72317

object_name: gastric cancer


subject: CHEBI:72317

object_name: Neck Carcinoma


subject: CHEBI:72317

object_name: head and neck neoplasm


subject: CHEBI:72317

object_name: head and neck cancer


subject: CHEBI:72317


subject: CHEBI:102265

subject_name: Sulfamethazine

object_name: pulmonary tuberculosis


subject: CHEBI:133246

subject_name: Ligustrazine


subject: CHEBI:45394

subject_name: TMP


subject: CHEBI:46324

subject_name: trimethyl phosphate


subject: CHEBI:9533

subject_name: thiamine(1+) monophosphate


subject: CHEBI:17013

subject_name: dTMP


subject: CHEBI:63528


subject: CHEBI:45924

subject_name: Trimethoprim


subject: UMLS:C0384479

subject_name: epithelial membrane protein-1


subject: PR:000007062

subject_name: epithelial membrane protein 1


subject: UniProtKB:P36590

subject_name: KTHY_SCHPO Thymidylate kinase (sprot)


subject: UMLS:C0133583

subject_name: oat beta-glucan

object_name: type 2 diabetes mellitus


subject: UMLS:C0767948

object_name: essential thrombocythemia


subject: UMLS:C0767948

object_name: acquired polycythemia vera


subject: PUBCHEM.COMPOUND:9867822

subject_name: Lestaurtinib

object_name: myelofibrosis


subject: PUBCHEM.COMPOUND:9867822


subject: PUBCHEM.COMPOUND:9867822


subject: CHEBI:91471


subject: CHEBI:91471


subject: CHEBI:91471


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: benign paroxysmal positional vertigo


subject: CHEBI:89324

object_name: dizziness


subject: CHEBI:89324

object_name: Vertigo as late effect of cerebrovascular disease


subject: CHEBI:89324

object_name: Vertigo, CTCAE


subject: CHEBI:89324

object_name: Calcium deficiency


subject: CHEBI:89324

object_name: peripheral vertigo


subject: CHEBI:89324

object_name: dizziness; epidemic


subject: CHEBI:89324

object_name: Dizziness, CTCAE 5.0


subject: CHEBI:89324

object_name: Dizziness, CTCAE 3.0


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Malignant neoplasm of the central nervous system


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: UMLS:C4723692

subject_name: Vandetanib-eluting Radiopaque Bead BTG-002814

object_name: metastatic colorectal cancer


subject: UMLS:C4723692

object_name: liver carcinoma


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Atopic rhinitis


subject: CHEBI:6129

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:7862

subject_name: Oxymetazoline


subject: CHEBI:71940

subject_name: Tadalafil

object_name: brain small vessel disease 3


subject: CHEBI:71940

object_name: Ischemic stroke


subject: CHEBI:190735

subject_name: Arbaclofen

object_name: fragile X syndrome


subject: CHEBI:15379

subject_name: Oxygen

object_name: decompression sickness


subject: UNII:PUY08529FK

subject_name: Eleclazine

object_name: long QT syndrome 3


subject: UNII:PUY08529FK

object_name: Long QT syndrome type 3


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: male breast carcinoma


subject: UNII:M89N0Q7EQR

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:M89N0Q7EQR

object_name: Carcinoma breast stage IV


subject: UNII:M89N0Q7EQR

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Breast cancer recurrent


subject: UNII:M89N0Q7EQR

object_name: HER2 positive breast carcinoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:44915

subject_name: Propofol

object_name: Sedation complication


subject: CHEBI:44915

object_name: adverse effect to anesthesia


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Rotator cuff tear


subject: UNII:WJA5UO9E10

subject_name: Orelabrutinib

object_name: marginal zone lymphoma


subject: UNII:WJA5UO9E10

object_name: MALT lymphoma


subject: UMLS:C0042210

subject_name: Vaccines

object_name: EXCESS LMW-DNA


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: CHEBI:151315

subject_name: Heparin

object_name: Metastatic malignant neoplasm to liver


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:E47C0NF7LV

object_name: colorectal cancer


subject: UNII:E47C0NF7LV

object_name: colorectal carcinoma


subject: UNII:E47C0NF7LV

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: UNII:8NZ41MIK1O


subject: CHEBI:7986

subject_name: Pentoxifylline


subject: CHEBI:7986


subject: CHEBI:7986


subject: CHEBI:7986


subject: CHEBI:9907

subject_name: ursodiol


subject: CHEBI:9907


subject: CHEBI:9907


subject: CHEBI:9907


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:84094

object_name: metabolic syndrome X


subject: CHEBI:84094

object_name: impotence


subject: CHEBI:84094

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:84094

object_name: Erectile dysfunction


subject: CHEBI:84094

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:84094

object_name: obesity


subject: CHEBI:84094

object_name: Obesity, CTCAE


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:4453

subject_name: Desogestrel

object_name: Uses oral contraception (finding)


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:231666

object_name: COPD, severe early onset


subject: CHEBI:231666

object_name: chronic obstructive pulmonary disease


subject: CHEBI:8892


subject: CHEBI:8892

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C0875967

subject_name: Avandia


subject: UMLS:C0875967


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: CHEBI:149504


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6801

subject_name: Metformin


subject: UMLS:C2346797

object_name: non-Hodgkin lymphoma


subject: UMLS:C2346797

object_name: acute lymphoblastic leukemia


subject: UNII:2NDX4B6N8F

subject_name: HA 22


subject: UNII:2NDX4B6N8F


subject: CHEBI:135905

subject_name: Terlipressin

object_name: Ascites


subject: CHEBI:135905

object_name: Ascites, CTCAE


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: neuromyelitis optica


subject: UMLS:C0085297

object_name: transverse myelitis


subject: UMLS:C0085297

object_name: acute transverse myelitis


subject: PR:000013518

subject_name: pyrin domain-containing protein 1

object_name: breast neoplasm


subject: UMLS:C3896845

subject_name: Recombinant Anti-WT1 Immunotherapeutic GSK2302024A


subject: CHEBI:6538

subject_name: Loratadine

object_name: adult lymphoma


subject: CHEBI:6538

object_name: lymphoma


subject: CHEBI:6538

object_name: pediatric lymphoma


subject: CHEBI:6538

object_name: leukemia


subject: CHEBI:6538

object_name: childhood leukemia


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: Hypercalciuria


subject: UMLS:C0812735

object_name: nephrolithiasis


subject: UMLS:C0812735

object_name: nephrocalcinosis


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:46081


subject: CHEBI:46081


subject: UMLS:C4684972

subject_name: Microtubule Inhibitor SCB01A

object_name: head and neck squamous cell carcinoma


subject: CHEBI:76978

subject_name: Tricaprylin

object_name: migraine


subject: CHEBI:76978

object_name: migraine with or without aura, susceptibility to, 1


subject: DRUGBANK:DB18421

object_name: retinal degeneration


subject: UMLS:C3890043

subject_name: Acoustic Coupling Fluid

object_name: glioma


subject: UMLS:C3890043

object_name: malignant glioma


subject: UMLS:C3890043

object_name: brain cancer


subject: UMLS:C3890043

object_name: brain neoplasm


subject: UNII:QEA2EG9S3E

subject_name: PUMITAMIG

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:91899

object_name: acute graft versus host disease


subject: CHEBI:91899

object_name: Intestinal Graft Versus Host Disease


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:3207


subject: CHEBI:135765

subject_name: Methylprednisolone hemisuccinate


subject: CHEBI:135765


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: malignant neoplasm of stomach metastatic to regional lymph nodes


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: MESH:C079198

subject_name: S 1 (combination)


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: RXCUI:284904

subject_name: Trizivir

object_name: HIV infection


subject: CHEBI:67271

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:67271

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:67271

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UMLS:C0242402

subject_name: Opioids

object_name: Chronic pain


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: coronary microvascular disorder


subject: CHEBI:16480

object_name: Intravascular hemolysis


subject: CHEBI:16480

object_name: cardiovascular disorder


subject: CHEBI:16480

object_name: Heart Disease Risk Factors


subject: UMLS:C5667084

subject_name: Basiliximab-IR700 RM-1995

object_name: skin squamous cell carcinoma


subject: UMLS:C5667084

object_name: cutaneous squamous cell carcinoma


subject: UMLS:C5667084

object_name: head and neck squamous cell carcinoma


subject: CHEBI:49140

object_name: pancreatic adenocarcinoma


subject: CHEBI:49140

object_name: disease


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: UMLS:C0013050

subject_name: Dormicum

object_name: Cytochrome p450 CYP3A enzyme deficiency


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:7581

subject_name: Nitrazepam


subject: CHEBI:51348

subject_name: tetraphene


subject: CHEBI:29022

subject_name: N-benzyladenine


subject: PUBCHEM.COMPOUND:53477793


subject: CHEBI:32594

subject_name: barium atom


subject: CHEBI:3087

subject_name: Betulinic Acid


subject: CHEBI:37136


subject: DRUGBANK:DB12481

subject_name: Barium


subject: UNII:SE2KH7T06F

object_name: trabecular adenocarcinoma


subject: UNII:SE2KH7T06F

object_name: cutaneous neuroendocrine carcinoma


subject: UNII:SE2KH7T06F

object_name: small cell carcinoma


subject: UNII:SE2KH7T06F

object_name: small cell lung carcinoma


subject: UMLS:C1328107


subject: UMLS:C1328107


subject: UMLS:C1328107

object_name: ovarian cancer


subject: UMLS:C1328107

object_name: ovarian neoplasm


subject: UMLS:C1328107

object_name: ovarian carcinoma


subject: UMLS:C1328107


subject: UMLS:C1328107


subject: CHEBI:6717

subject_name: Mefenamic acid

object_name: Abnormal uterine bleeding


subject: PUBCHEM.COMPOUND:62005

subject_name: TOBRAMYCIN SULFATE

object_name: Prosthetic joint infection


subject: CHEBI:28864

subject_name: Tobramycin


subject: CHEBI:9932

subject_name: Vancomycin hydrochloride


subject: CHEBI:28001

subject_name: Vancomycin


subject: UMLS:C0205992

subject_name: vancomycin hydrochloride


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: inflammatory bowel disease 1


subject: CHEBI:46245

object_name: Crohn disease


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: basal cell carcinoma


subject: CHEBI:30314

object_name: skin basal cell carcinoma


subject: CHEBI:46217

subject_name: L-alanine residue


subject: CHEBI:46217


subject: CHEBI:158283

subject_name: Ala-Leu-Ala


subject: CHEBI:158283


subject: CHEBI:16449

subject_name: DL-Alanine


subject: CHEBI:16449


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:43796


subject: CHEBI:17549

subject_name: Aminolevulinic acid


subject: CHEBI:17549


subject: CHEBI:27432

subject_name: linolenic acid


subject: CHEBI:27432


subject: CHEBI:16977

subject_name: Alanine


subject: CHEBI:16977


subject: CHEBI:231673

subject_name: Hyaluronidase

object_name: type 1 diabetes mellitus 1


subject: PUBCHEM.COMPOUND:91820602


subject: UMLS:C3489693

object_name: Depressed mood


subject: UMLS:C3489693

object_name: Cancer patients and suicide and depression


subject: UMLS:C3489693

object_name: Depressed - symptom


subject: UMLS:C3489693

object_name: Depression, CTCAE


subject: UNII:E3B2GI648A

subject_name: Belatacept

object_name: Renal transplant rejection


subject: UMLS:C4688466

subject_name: INCMGA 0012

object_name: carcinoma of esophagus


subject: UMLS:C4688466

object_name: esophageal cancer


subject: UMLS:C4688466

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C4688466

object_name: neoplasm of esophagus


subject: CHEBI:6121

subject_name: Ketamine

object_name: Amputation, Traumatic


subject: UMLS:C5400804

subject_name: TTR Stabilizer AG10

object_name: Transthyretin-related (ATTR) familial amyloid polyneuropathy


subject: CHEBI:84500

subject_name: varenicline

object_name: acute coronary syndrome


subject: MESH:C511203

subject_name: COLD-fX

object_name: Atopic rhinitis


subject: MESH:C511203

object_name: Hay fever


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Kaposi Sarcoma


subject: CHEBI:63791

object_name: Recurrent Kaposi Sarcoma


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Vasospasm


subject: CHEBI:16796

subject_name: Melatonin


subject: UMLS:C5706299

subject_name: Tecadriol

object_name: Androgen excess


subject: CHEBI:74947

subject_name: Thalidomide

object_name: Obscure gastrointestinal hemorrhage


subject: CHEBI:74947

object_name: angiodysplasia


subject: CHEBI:64816

object_name: retroperitoneal sarcoma


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:2639

subject_name: Amiloride

object_name: type 2 diabetes mellitus


subject: CHEBI:2639

object_name: Insulin resistance


subject: CHEBI:2639

object_name: Overweight and obesity


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: adult lymphoma


subject: UNII:C8ADC441ME

object_name: lymphoma


subject: UNII:C8ADC441ME

object_name: pediatric lymphoma


subject: UNII:C8ADC441ME

object_name: Autonomic nervous system imbalance


subject: CHEBI:4856

subject_name: Esmolol

object_name: Frailty


subject: CHEBI:4856

object_name: Myocardial injury


subject: CHEBI:188074

object_name: hypertension


subject: CHEBI:188074

object_name: Hypertension, CTCAE


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Cachexia


subject: CHEBI:6456

subject_name: Lidocaine

object_name: opioid use


subject: CHEBI:6456

object_name: liver cancer


subject: CHEBI:6456

object_name: liver neoplasm


subject: CHEBI:6456

object_name: Adult Liver Carcinoma


subject: CHEBI:6456

object_name: liver carcinoma


subject: CHEBI:6456

object_name: Metastatic malignant neoplasm to liver


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: colorectal carcinoma


subject: UNII:6QVL057INT

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C5706358

subject_name: Bi-Sialidase Fusion Protein E-602

object_name: cancer


subject: UMLS:C5706358

object_name: neoplasm


subject: UMLS:C5706358

object_name: colon carcinoma


subject: UMLS:C5706358

object_name: colorectal cancer


subject: UMLS:C5706358

object_name: colon cancer


subject: UMLS:C5706358

object_name: Childhood Breast Carcinoma


subject: UMLS:C5706358

object_name: breast carcinoma


subject: UMLS:C5706358

object_name: breast cancer


subject: UMLS:C5706358

object_name: bladder tumor


subject: UMLS:C5706358

object_name: urinary bladder carcinoma


subject: UMLS:C5706358

object_name: urinary bladder cancer


subject: UMLS:C5706358

object_name: childhood bladder carcinoma


subject: UMLS:C5706358

object_name: ovarian cancer


subject: UMLS:C5706358

object_name: ovarian neoplasm


subject: UMLS:C5706358

object_name: ovarian carcinoma


subject: UMLS:C5706358

object_name: Stomach cancer


subject: UMLS:C5706358

object_name: gastric cancer


subject: UMLS:C5706358

object_name: Neck Carcinoma


subject: UMLS:C5706358

object_name: head and neck neoplasm


subject: UMLS:C5706358

object_name: head and neck cancer


subject: UMLS:C5706358

object_name: pancreatic neoplasm


subject: UMLS:C5706358

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5706358

object_name: malignant pancreatic neoplasm


subject: UMLS:C5706358

object_name: colorectal carcinoma


subject: UMLS:C5706358

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5706358

object_name: non-small cell lung carcinoma


subject: UMLS:C5706358

object_name: melanoma


subject: UMLS:C5690451

subject_name: Lian Hua Qing Wen


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: liver cirrhosis


subject: UMLS:C1831965

object_name: glioblastoma


subject: UMLS:C1831965

object_name: Brain Stem Glioblastoma


subject: UMLS:C1831965

object_name: glioma susceptibility 1


subject: CHEBI:15765

subject_name: Levodopa

object_name: Motor function (finding)


subject: CHEBI:15765

object_name: Impulsive character (finding)


subject: CHEBI:15765

object_name: Impulsivity


subject: CHEBI:133246

subject_name: Ligustrazine

object_name: urinary tract infection


subject: CHEBI:133246

object_name: bacterial urinary tract infection


subject: CHEBI:133246

object_name: Urinary Tract Infection, CTCAE


subject: CHEBI:45394

subject_name: TMP


subject: CHEBI:45394


subject: CHEBI:45394


subject: CHEBI:46324

subject_name: trimethyl phosphate


subject: CHEBI:46324


subject: CHEBI:46324


subject: CHEBI:9533

subject_name: thiamine(1+) monophosphate


subject: CHEBI:9533


subject: CHEBI:9533


subject: CHEBI:17013

subject_name: dTMP


subject: CHEBI:17013


subject: CHEBI:17013


subject: CHEBI:63528


subject: CHEBI:63528


subject: CHEBI:63528


subject: CHEBI:45924

subject_name: Trimethoprim


subject: UMLS:C0384479

subject_name: epithelial membrane protein-1


subject: UMLS:C0384479


subject: UMLS:C0384479


subject: PR:000007062

subject_name: epithelial membrane protein 1


subject: PR:000007062


subject: PR:000007062


subject: UniProtKB:P36590

subject_name: KTHY_SCHPO Thymidylate kinase (sprot)


subject: UniProtKB:P36590


subject: UniProtKB:P36590


subject: UNII:WTT295HSY5

subject_name: Dulaglutide

object_name: Thirst symptom


subject: UNII:WTT295HSY5

object_name: Water-Electrolyte Imbalance


subject: UMLS:C2976495


subject: UMLS:C2976495


subject: UMLS:C2983727

subject_name: ensituximab

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C2983727

object_name: metastatic colorectal cancer


subject: UMLS:C4507351


subject: UMLS:C4507351


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: urothelial carcinoma


subject: CHEBI:194095

object_name: transitional cell carcinoma


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: MESH:C000721530

subject_name: andrographolide sulfonate

object_name: acute tonsillitis


subject: CHEBI:7496

subject_name: Nelfinavir

object_name: non-small cell lung carcinoma


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C3714803

object_name: amyotrophic lateral sclerosis


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: UMLS:C2346492

subject_name: Indocyanine Green Solution

object_name: rectal carcinoma


subject: UMLS:C2346492

object_name: rectal cancer


subject: UMLS:C2346492

object_name: Childhood Rectal Carcinoma


subject: UMLS:C2346492

object_name: Surgical procedure finding


subject: UMLS:C2346492

object_name: Injury of urethra


subject: CHEBI:135783

subject_name: Etiprednol dicloacetate

object_name: Crohn disease


subject: UNII:QC4F7FKK7I

subject_name: Faricimab

object_name: Wet age-related macular degeneration


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: hematologic disorder


subject: CHEBI:174615


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: type 1 diabetes mellitus 1


subject: UNII:4F4X42SYQ6

object_name: type 1 diabetes mellitus


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:49900

object_name: myoclonic dystonia 11


subject: CHEBI:49900

object_name: myeloid neoplasm


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: CHEMBL.COMPOUND:CHEMBL5314347

subject_name: SEVELAMER CARBONATE

object_name: end stage renal failure


subject: CHEMBL.COMPOUND:CHEMBL5314347

object_name: chronic kidney disease


subject: CHEMBL.COMPOUND:CHEMBL5314347

object_name: Chronic uremia


subject: UMLS:C2984025

subject_name: Ferinject

object_name: metastatic colorectal cancer


subject: UMLS:C2346919

subject_name: Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine

object_name: Childhood Breast Carcinoma


subject: UMLS:C2346919

object_name: breast carcinoma


subject: UMLS:C2346919

object_name: breast cancer


subject: UMLS:C0301532

subject_name: Multivitamin preparation

object_name: Avitaminosis


subject: UMLS:C3714835

subject_name: Multivitamin Drug Class


subject: UNII:21K6M2I7AG

subject_name: interferon gamma-1b

object_name: cystic fibrosis


subject: UMLS:C0021741

subject_name: Actimmune


subject: CHEBI:30879

subject_name: alcohol

object_name: hypertension


subject: CHEBI:30879

object_name: Hypertension, CTCAE


subject: CHEBI:30879

object_name: essential hypertension


subject: CHEBI:16236

subject_name: Ethanol


subject: UMLS:C1510427

subject_name: Recombinant MAGE-3.1 Antigen

object_name: melanoma


subject: UMLS:C4722357

subject_name: R848 Gel


subject: CHEBI:134716

subject_name: Brexpiprazole

object_name: bipolar disorder


subject: CHEBI:134716

object_name: bipolar depression


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Incomplete reversal of neuromuscular block


subject: CHEBI:50733

subject_name: nutraceutical

object_name: pancreatic neoplasm


subject: CHEBI:50733

object_name: exocrine pancreatic carcinoma


subject: CHEBI:50733

object_name: malignant pancreatic neoplasm


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: epidural spinal canal neoplasm


subject: PR:000001151

subject_name: Toll-like receptor 1

object_name: digestive system neoplasm


subject: PR:000001151

object_name: Neoplasm of the gastrointestinal tract


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Non-small cell lung cancer stage IIIB


subject: PUBCHEM.COMPOUND:1805

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:132082

subject_name: Entinostat

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082

object_name: Non-small cell lung cancer recurrent


subject: UNII:768FW21J3L

subject_name: Famitinib

object_name: Colorectal cancer recurrent


subject: UNII:768FW21J3L

object_name: metastatic colorectal cancer


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Quadriceps muscle atrophy


subject: PUBCHEM.COMPOUND:2735

object_name: Anterior Cruciate Ligament Injuries


subject: PUBCHEM.COMPOUND:2735

object_name: Anterior Cruciate Ligament Tear


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:62880

subject_name: Veliparib

object_name: fallopian tube carcinoma


subject: CHEBI:62880

object_name: fallopian tube cancer


subject: CHEBI:62880

object_name: primary peritoneal carcinoma


subject: CHEBI:62880

object_name: Primary Peritoneal Cancer


subject: UMLS:C1831920

subject_name: ABT 888


subject: UMLS:C1831920


subject: UMLS:C1831920

object_name: triple-negative breast carcinoma


subject: UMLS:C1831920

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C1831920


subject: UMLS:C1831920


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: Sicca Syndrome


subject: UNII:73B0K5S26A

object_name: childhood acute lymphoblastic leukemia


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:55KHL3P693

subject_name: Galcanezumab

object_name: Transformed migraine


subject: MESH:D056692

subject_name: Prebiotics

object_name: atopic eczema


subject: CHEBI:30884

subject_name: glycoloyl group

object_name: Autoimmunity


subject: CHEBI:73890

subject_name: Gly-Cys


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: hepatitis D


subject: CHEBI:63716

subject_name: TENOFOVIR


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: CHEBI:63625

subject_name: Tenofovir


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: bipolar disorder


subject: GTOPDB:9310

subject_name: lirilumab

object_name: cancer


subject: UNII:S9XDI9W918

subject_name: LIRILUMAB


subject: UMLS:C3641620


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: proliferative diabetic retinopathy


subject: CHEBI:59204

subject_name: Carbetocin

object_name: Dysesthesia


subject: CHEBI:59204

object_name: Central Nervous System Sensitization


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: primary disorders


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50695

subject_name: monobactam

object_name: penicillin allergy


subject: CHEBI:50695

object_name: Allergy to penicillin


subject: CHEBI:27933

subject_name: beta-lactam antibiotic


subject: CHEBI:27933


subject: CHEBI:2639

subject_name: Amiloride

object_name: Edema


subject: CHEBI:2639

object_name: nephrotic syndrome


subject: CHEBI:2639

object_name: Nephrotic Syndrome, CTCAE


subject: CHEBI:2639

object_name: Sodium retention


subject: CHEBI:2639

object_name: Hypernatremia


subject: UMLS:C5706513

subject_name: Stapokibart

object_name: Nasal Polyp


subject: UMLS:C5706513

object_name: chronic rhinosinusitis


subject: CHEBI:16335

subject_name: Adenosine

object_name: heart failure


subject: CHEBI:16335

object_name: Heart Failure, CTCAE


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Fetal or neonatal effect of induction of labor


subject: CHEBI:30006

subject_name: L-leucine residue

object_name: major depressive disorder


subject: CHEBI:25017

subject_name: leucine


subject: CHEBI:119915

subject_name: Fentanyl

object_name: female reproductive system disorder


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:76989

subject_name: phytoestrogen

object_name: infertility


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Locally Advanced Malignant Neoplasm


subject: UNII:M89N0Q7EQR

object_name: Unresectable Malignant Neoplasm


subject: UNII:M89N0Q7EQR

object_name: malignant soft tissue neoplasm


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:174615


subject: CHEBI:174615

object_name: HLA-A*0201 Positive Cells Present


subject: CHEBI:174615


subject: CHEBI:174615

object_name: NY-ESO-1 Positive Tumor Cells Present


subject: CHEBI:174615


subject: CHEBI:174615

object_name: sarcoma


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:125354

subject_name: Plerixafor


subject: CHEBI:125354


subject: CHEBI:125354


subject: CHEBI:125354


subject: CHEBI:125354


subject: CHEBI:125354


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: IgA Nephropathy


subject: CHEBI:82715

object_name: osteoarthritis


subject: PUBCHEM.COMPOUND:21873174

subject_name: Testosterone undecanoate

object_name: Low-Calorie Diet


subject: UMLS:C0302909

subject_name: solid substance

object_name: type 2 diabetes mellitus


subject: UMLS:C0302909

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0302909

object_name: obesity


subject: UMLS:C0302909

object_name: Obesity, CTCAE


subject: CHEBI:94366

subject_name: itraconazole

object_name: anaplastic large cell lymphoma


subject: UMLS:C1957666


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEBI:28939

object_name: non-verbal learning disability


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS


subject: UNII:71M78END5S

object_name: pervasive developmental disorder


subject: UNII:71M78END5S

object_name: autism


subject: UNII:71M78END5S

object_name: autism spectrum disorder


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEBI:25681


subject: CHEBI:25681


subject: CHEBI:24848

subject_name: inositol


subject: CHEBI:24848


subject: CHEBI:24848


subject: CHEBI:24848


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: Urinary Urgency


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: GTOPDB:13709

subject_name: olpasiran

object_name: cardiovascular disorder


subject: DRUGBANK:DB19001

subject_name: Olpasiran


subject: CHEBI:18067

subject_name: Phylloquinone


subject: UNII:768FW21J3L

subject_name: Famitinib

object_name: non-small cell lung carcinoma


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: lumbar spinal stenosis


subject: CHEBI:94518

object_name: spinal stenosis


subject: CHEBI:94518

object_name: Spinal stenosis of thoracic region


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Left Ventricular Systolic Dysfunction, CTCAE 3.0


subject: CHEBI:85078

object_name: Left Ventricular Systolic Dysfunction, CTCAE 5.0


subject: CHEBI:85078

object_name: Left ventricular systolic dysfunction


subject: CHEBI:85078

object_name: ST-elevation myocardial infarction


subject: CHEBI:3286

subject_name: Cabergoline

object_name: Complication associated with artificial fertilization, unspecified


subject: CHEBI:3286

object_name: Ovarian failure


subject: DRUGBANK:DB09106

subject_name: hetastarch


subject: DRUGBANK:DB09106


subject: UNII:4ADT8JXB9S

object_name: asthma


subject: UMLS:C4045791


subject: CHEBI:5312

subject_name: gentamicin sulfate

object_name: recessive dystrophic epidermolysis bullosa


subject: UNII:8X7386QRLV

subject_name: GENTAMICIN SULFATE


subject: UNII:KV1M7Q3CBP

object_name: leukemia, myeloid, accelerated-phase


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: gastroesophageal cancer


subject: GTOPDB:7394

subject_name: gevokizumab

object_name: nonpapillary renal cell carcinoma


subject: GTOPDB:7394

object_name: clear cell renal carcinoma


subject: GTOPDB:7394

object_name: renal cell adenocarcinoma


subject: GTOPDB:7394

object_name: renal cell carcinoma


subject: GTOPDB:7394

object_name: colorectal cancer


subject: GTOPDB:7394

object_name: colorectal carcinoma


subject: GTOPDB:7394

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: GTOPDB:7394


subject: CHEMBL.COMPOUND:CHEMBL1743026

subject_name: GEVOKIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743026


subject: CHEMBL.COMPOUND:CHEMBL1743026


subject: CHEMBL.COMPOUND:CHEMBL1743026


subject: CHEMBL.COMPOUND:CHEMBL1743026


subject: CHEMBL.COMPOUND:CHEMBL1743026


subject: CHEMBL.COMPOUND:CHEMBL1743026


subject: CHEMBL.COMPOUND:CHEMBL1743026


subject: UMLS:C3179523


subject: UMLS:C3179523


subject: UMLS:C3179523


subject: UMLS:C3179523


subject: UMLS:C3179523


subject: UMLS:C3179523


subject: UMLS:C3179523


subject: UMLS:C3179523


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UMLS:C1721684

subject_name: lexatumumab


subject: CHEBI:51041

subject_name: Acamprosate

object_name: binge eating


subject: UMLS:C0920324

subject_name: Homeopathic Remedies

object_name: Adjustment reaction with physical symptoms


subject: KEGG.COMPOUND:C00374

subject_name: Heparin

object_name: plasma cell myeloma


subject: UMLS:C0071315

subject_name: Pneumovax

object_name: streptococcal pneumonia


subject: UMLS:C1450556

subject_name: aviscumine

object_name: melanoma


subject: PUBCHEM.COMPOUND:162513664

subject_name: OBELDESIVIR

object_name: respiratory syncytial virus infectious disease


subject: DRUGBANK:DB18821

subject_name: Obeldesivir


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: head and neck squamous cell carcinoma


subject: UMLS:C3896806


subject: CHEBI:65353

subject_name: Lorcaserin

object_name: Weight Gain


subject: CHEBI:65353

object_name: Weight Gain, CTCAE


subject: CHEBI:84500

subject_name: varenicline


subject: CHEBI:84500


subject: CHEMBL.COMPOUND:CHEMBL2108924

subject_name: CINNAMON

object_name: dental caries


subject: CHEMBL.COMPOUND:CHEMBL2108924

object_name: Dental Caries, CTCAE


subject: UMLS:C0939899

subject_name: cinnamon preparation


subject: UMLS:C0939899


subject: CHEMBL.COMPOUND:CHEMBL2108465

subject_name: GINGER


subject: CHEMBL.COMPOUND:CHEMBL2108465


subject: UNII:C5529G5JPQ

subject_name: ginger extract


subject: UNII:C5529G5JPQ


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: Anorexia


subject: CHEBI:6950

object_name: Anorexia, CTCAE


subject: CHEBI:6950

object_name: Anorexia symptom


subject: CHEBI:65345

subject_name: Sonolisib

object_name: prostate carcinoma


subject: CHEBI:65345

object_name: prostate cancer


subject: UMLS:C5966119

subject_name: CDK2 Inhibitor AVZO-021

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5966119

object_name: CDK4 Gene Amplification


subject: UMLS:C5966119

object_name: CCND1 Gene Amplification


subject: UMLS:C5966119

object_name: CDK Gene Mutation


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:6413


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone

object_name: Turner syndrome


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: UNII:8FUE2D4G82

subject_name: VILASTOBART


subject: UMLS:C5908926

subject_name: Vilastobart


subject: UMLS:C5556560

subject_name: Anti-CTLA-4 Monoclonal Antibody XTX101


subject: UNII:OSL3FEZ1IF

subject_name: Lisaftoclax

object_name: diffuse large B-cell lymphoma


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Pathologic vasoconstriction


subject: CHEBI:40279

object_name: Vasoconstriction


subject: CHEBI:40279

object_name: cardiovascular disorder


subject: CHEBI:40279

object_name: Heart Disease Risk Factors


subject: CHEBI:2781

subject_name: Apocynin


subject: CHEBI:2781


subject: CHEBI:2781


subject: CHEBI:2781


subject: CHEBI:15372


subject: CHEBI:15372


subject: CHEBI:15372


subject: CHEBI:15372


subject: PUBCHEM.COMPOUND:5320784

subject_name: Pterosin E


subject: PUBCHEM.COMPOUND:5320784


subject: PUBCHEM.COMPOUND:5320784


subject: PUBCHEM.COMPOUND:5320784


subject: CHEBI:59560

subject_name: Sapropterin


subject: CHEBI:59560


subject: CHEBI:59560


subject: CHEBI:59560


subject: CHEBI:32139

object_name: Coronavinae infectious disease


subject: UMLS:C2604734

subject_name: briakinumab

object_name: Chronic small plaque psoriasis


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: malignant soft tissue neoplasm


subject: CHEBI:81579

object_name: sarcoma


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: esophageal disorder


subject: CHEBI:63584

object_name: gastroesophageal cancer


subject: CHEBI:63584

object_name: Stomach cancer


subject: CHEBI:63584

object_name: gastric cancer


subject: PR:000005503

object_name: bronchiolitis obliterans syndrome


subject: PR:000005503

object_name: graft versus host disease


subject: PR:000005503

object_name: Bronchiolitis, Exudative


subject: PR:000005503

object_name: Bronchiolitis, Proliferative


subject: UNII:6DC9826KIM

object_name: Myelodysplasia


subject: UNII:6DC9826KIM

object_name: Adult Myelodysplastic Syndrome


subject: UNII:6DC9826KIM

object_name: childhood myelodysplastic syndrome


subject: UNII:6DC9826KIM

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C3640099

subject_name: Immunomodulatory Agent CC-11006


subject: UMLS:C3640099


subject: UMLS:C3640099


subject: UMLS:C3640099


subject: CHEBI:231342

subject_name: ceralasertib

object_name: Small cell lung cancer extensive stage


subject: CHEBI:4856

subject_name: Esmolol

object_name: brain neoplasm


subject: CHEBI:180905

subject_name: Nicardipine


subject: UMLS:C0677669

object_name: Neck Carcinoma


subject: UMLS:C0677669

object_name: head and neck neoplasm


subject: UMLS:C0677669

object_name: head and neck cancer


subject: PUBCHEM.COMPOUND:2269

object_name: Severe Acute Malnutrition


subject: PUBCHEM.COMPOUND:2269

object_name: Child Malnutrition


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: UMLS:C4085979

object_name: Advanced Melanoma


subject: UMLS:C4722236

subject_name: Acacia senegal extract

object_name: Androgen excess


subject: UNII:7K28NB895L

subject_name: Belzutifan

object_name: Advanced Gastrointestinal Stromal Tumor


subject: UNII:7K28NB895L

object_name: pancreatic neuroendocrine tumor


subject: PUBCHEM.COMPOUND:157010100

subject_name: Potassium citrate

object_name: nephrolithiasis


subject: PUBCHEM.COMPOUND:157010100

object_name: cystinuria


subject: PUBCHEM.COMPOUND:157010100

object_name: interstitial nephritis


subject: PUBCHEM.COMPOUND:157010100

object_name: glomerulonephritis


subject: CHEBI:8871

subject_name: Risperidone

object_name: treatment resistant depression


subject: CHEBI:8871


subject: CHEBI:37956

subject_name: histamine antagonist

object_name: Recurrent Ependymoma


subject: CHEBI:37956

object_name: Recurrent Childhood Ependymoma


subject: CHEBI:37956

object_name: Recurrent Medulloblastoma


subject: CHEBI:37956

object_name: Recurrent Childhood Medulloblastoma


subject: UMLS:C0740098

subject_name: Antihistamine brand of Diphenhydramine


subject: UMLS:C0740098


subject: UMLS:C0740098


subject: UMLS:C0740098


subject: UMLS:C0019592

subject_name: Histamine H1 Antagonists


subject: UMLS:C0019592


subject: UMLS:C0019592


subject: UMLS:C0019592


subject: UMLS:C3536809

subject_name: Antihistamine [EPC]


subject: UMLS:C3536809


subject: UMLS:C3536809


subject: UMLS:C3536809


subject: CHEBI:35493

subject_name: antipyretic


subject: CHEBI:35493


subject: CHEBI:35493


subject: CHEBI:35493


subject: UMLS:C0003419

subject_name: Antipyretics


subject: UMLS:C0003419


subject: UMLS:C0003419


subject: UMLS:C0003419


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:18258

subject_name: Liothyronine


subject: CHEBI:18258


subject: CHEBI:18258


subject: CHEBI:18258


subject: UNII:B6PMV8U3C4

subject_name: omburtamab I-131


subject: UNII:B6PMV8U3C4


subject: UNII:B6PMV8U3C4


subject: UNII:B6PMV8U3C4


subject: UMLS:C1541591


subject: UMLS:C1541591


subject: UMLS:C1541591


subject: UMLS:C1541591


subject: UMLS:C1564085

subject_name: SSKI


subject: UMLS:C1564085


subject: UMLS:C1564085


subject: UMLS:C1564085


subject: CHEBI:8346

subject_name: Potassium Iodide


subject: CHEBI:8346


subject: CHEBI:8346


subject: CHEBI:8346


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:50919

subject_name: antiemetic


subject: CHEBI:50919


subject: CHEBI:50919


subject: CHEBI:50919


subject: UMLS:C0003297

subject_name: Antiemetics


subject: UMLS:C0003297


subject: UMLS:C0003297


subject: UMLS:C0003297


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: atopic eczema


subject: CHEBI:201431

object_name: dermatitis


subject: CHEBI:201431

object_name: Eczema, CTCAE


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:44915

subject_name: Propofol

object_name: Shoulder dislocation


subject: CHEBI:8802

subject_name: Remifentanil


subject: UNII:8BR2SOL3L1

object_name: Metastatic Renal Cell Carcinoma


subject: UNII:8BR2SOL3L1

object_name: Metastatic Renal Cell Cancer


subject: DRUGBANK:DB12813

subject_name: Radium Ra-223


subject: DRUGBANK:DB12813


subject: CHEBI:74067

subject_name: Ile-Ile

object_name: Ischemic cerebrovascular disease


subject: CHEBI:74067

object_name: Safety Issues


subject: PR:000001822

subject_name: MHC class II histocompatibility antigen gamma chain


subject: PR:000001822


subject: PR:000007904


subject: PR:000007904


subject: CHEBI:48923

subject_name: erythromycin

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:48923

object_name: COPD, severe early onset


subject: CHEBI:48923

object_name: chronic obstructive pulmonary disease


subject: CHEBI:42355

subject_name: Erythromycin


subject: CHEBI:42355


subject: CHEBI:42355


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: Cervix carcinoma recurrent


subject: CHEBI:231005

object_name: Stage IVA Cervical Cancer AJCC v8


subject: CHEBI:231005

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: CHEBI:231005

object_name: Cervical carcinoma stage IVA


subject: CHEBI:231005

object_name: Cervical carcinoma stage IVB


subject: CHEBI:231005

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: CHEBI:231005

object_name: Stage IVB Cervical Cancer AJCC v8


subject: CHEBI:231005

object_name: Stage IIIB Cervical Cancer AJCC v6 and v7


subject: CHEBI:231005

object_name: Stage IIIB Cervical Cancer AJCC v8


subject: CHEBI:231005

object_name: Stage IIIA Cervical Cancer AJCC v8


subject: CHEBI:231005

object_name: Stage IIIA Cervical Cancer AJCC v6 and v7


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Hormone-dependent prostate cancer


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C1327972

subject_name: Fowlpox-PSA-TRICOM Vaccine


subject: UMLS:C4282329

subject_name: Prostvac-V


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Congenital postural scoliosis


subject: CHEBI:41879

object_name: scoliosis


subject: CHEBI:41879

object_name: Scoliosis, CTCAE


subject: CHEBI:41879

object_name: idiopathic scoliosis


subject: CHEBI:41879

object_name: adolescent idiopathic scoliosis


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: neuroma


subject: CHEBI:28939

object_name: carpal tunnel syndrome


subject: CHEBI:28939

object_name: carpal tunnel syndrome 1


subject: CHEBI:28939

object_name: Interosseous desmitis


subject: CHEBI:28939

object_name: Hand Injuries and Disorders


subject: UMLS:C4085977

subject_name: Anti-OX40 Monoclonal Antibody GSK3174998

object_name: neoplasm


subject: UMLS:C4287758

subject_name: Feladilimab


subject: CHEBI:53315

subject_name: poly[9,9-bis((6'-N,N,N-trimethylammonium)hexyl)fluorenylene phenylene dibromide] macromolecule

object_name: chronic inflammatory demyelinating polyradiculoneuropathy


subject: CHEBI:53315

object_name: polyneuropathy, inflammatory demyelinating, chronic


subject: CHEBI:60588

subject_name: poly[9,9-bis((6'-N,N,N-trimethylammonium)hexyl)fluorenylene phenylene dibromide] polymer


subject: CHEBI:60588


subject: CHEBI:31980

subject_name: Perflutren


subject: CHEBI:31980


subject: UniProtKB:P35763

subject_name: PERF_RAT Perforin-1 (sprot)


subject: UniProtKB:P35763


subject: PR:000003466


subject: PR:000003466


subject: UMLS:C2981817

subject_name: Tomato-Soy Juice

object_name: prostate carcinoma


subject: CHEBI:6413

subject_name: Letrozole

object_name: fallopian tube carcinoma


subject: CHEBI:6413

object_name: fallopian tube cancer


subject: CHEBI:6413

object_name: peritoneum cancer


subject: UMLS:C1327963

object_name: non-small cell lung carcinoma


subject: UMLS:C0594372

subject_name: Avonex

object_name: Multiple sclerosis relapse


subject: UMLS:C0594372

object_name: Clinically isolated syndrome


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:77562

object_name: Childhood Solid Neoplasm


subject: CHEBI:77562

object_name: Neuroblastoma recurrent


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:50223

subject_name: Dexrazoxane


subject: CHEBI:50223


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:63632


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:30347

subject_name: Ethylenediamine

object_name: Critical Illness


subject: CHEBI:30347

object_name: acute kidney failure


subject: CHEBI:30347

object_name: cardiac arrest


subject: CHEBI:30347

object_name: Cardiac Arrest, CTCAE


subject: CHEBI:30347

object_name: type 2 diabetes mellitus


subject: CHEBI:30347

object_name: Diabetes


subject: CHEBI:30347

object_name: diabetes mellitus


subject: CHEBI:30347

object_name: Sepsis


subject: CHEBI:30347

object_name: Sepsis, CTCAE


subject: CHEBI:30347

object_name: Shock


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Plasma cell tumor, malignant


subject: CHEBI:9168

object_name: plasma cell neoplasm


subject: UMLS:C0016004

subject_name: Beriplast P

object_name: cleft palate


subject: UMLS:C0016004

object_name: isolated cleft palate


subject: UMLS:C0016004

object_name: cleft palate on exam


subject: CHEBI:29999

subject_name: L-serine residue

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:29999

object_name: Obesity, Visceral


subject: CHEBI:29999

object_name: Postmenopausal


subject: CHEBI:17115

subject_name: Serine


subject: CHEBI:17115


subject: CHEBI:17115


subject: CHEBI:15727

subject_name: Carnosine


subject: CHEBI:15727


subject: CHEBI:15727


subject: UMLS:C0007267

subject_name: carnosine


subject: UMLS:C0007267


subject: UMLS:C0007267


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:9144

subject_name: Silibinin

object_name: Mushroom Poisoning


subject: CHEBI:9144

object_name: liver failure


subject: CHEBI:9144

object_name: Amanita poisoning


subject: CHEBI:172705

subject_name: DEHYDROSILYLBIN


subject: CHEBI:172705


subject: CHEBI:172705


subject: CHEBI:125451

subject_name: silymarin


subject: CHEBI:125451


subject: CHEBI:125451


subject: UNII:4RKY41TBTF

subject_name: SILIBININ


subject: UNII:4RKY41TBTF


subject: UNII:4RKY41TBTF


subject: RXCUI:352990

subject_name: Suboxone

object_name: cocaine abuse


subject: CHEBI:91899

object_name: Neonatal Respiratory Distress Syndrome, AE


subject: CHEBI:91899

object_name: Premature birth


subject: CHEBI:91899

object_name: Inflammatory Response


subject: CHEBI:91899

object_name: Neutrophil extracellular trap formation


subject: CHEBI:91899

object_name: lung; premature


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:3207


subject: CHEBI:3207


subject: CHEBI:3207


subject: CHEBI:3207


subject: UMLS:C5417993

subject_name: Porustobart

object_name: Advanced Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL3137344

subject_name: LATIGLUTENASE

object_name: celiac disease


subject: UMLS:C4508930


subject: CHEBI:180653

subject_name: Molnupiravir


subject: PUBCHEM.COMPOUND:70105374

subject_name: Pitavastatin Lactone

object_name: Recurrent Childhood Glioblastoma


subject: PUBCHEM.COMPOUND:70105374

object_name: Recurrent Glioblastoma


subject: PUBCHEM.COMPOUND:70105374

object_name: adult glioblastoma


subject: CHEBI:32020

subject_name: Pitavastatin


subject: CHEBI:32020


subject: CHEBI:32020


subject: UMLS:C3709450

subject_name: CALANUS OIL

object_name: Overweight


subject: UMLS:C0002007

subject_name: Aldosterone Antagonists

object_name: Conn's syndrome


subject: UMLS:C0002007

object_name: Appetite Disorders


subject: UMLS:C0002007

object_name: excess; salt


subject: UMLS:C3536833

subject_name: Aldosterone Antagonist [EPC]


subject: UMLS:C3536833


subject: UMLS:C3536833


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Parkinson disease


subject: CHEBI:3396

subject_name: Carbidopa-levodopa


subject: CHEBI:177705

subject_name: Birinapant

object_name: cancer


subject: CHEBI:177705

object_name: neoplasm


subject: UMLS:C2981814


subject: UMLS:C2981814


subject: PUBCHEM.COMPOUND:66621102

object_name: liver carcinoma


subject: CHEBI:85089

subject_name: Ledipasvir


subject: PUBCHEM.COMPOUND:66811198

subject_name: SIMEPREVIR


subject: CHEBI:82977

subject_name: Daclatasvir


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Ruminations


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:66910

subject_name: Axitinib

object_name: carcinoid tumor


subject: CHEBI:66910

object_name: neuroendocrine neoplasm


subject: CHEBI:66910

object_name: digestive system neuroendocrine neoplasm


subject: UMLS:C4724802

object_name: esophageal adenocarcinoma


subject: UMLS:C4724802

object_name: squamous cell carcinoma


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: pancreatic ductal adenocarcinoma


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: DRUGBANK:DB18668

object_name: interstitial lung disease 1


subject: DRUGBANK:DB18668

object_name: interstitial lung disease 2


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: Locally Advanced Lung Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: CHEBI:94686

subject_name: Orlistat

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:94686

object_name: metabolic syndrome X


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Surgical procedure finding


subject: CHEBI:25681

object_name: colorectal cancer


subject: CHEBI:25681

object_name: colorectal carcinoma


subject: CHEBI:25681

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:25681

object_name: Surgery--Complications


subject: CHEBI:25681

object_name: Postoperative Complications


subject: CHEBI:25681

object_name: Wound Infection


subject: CHEBI:25681

object_name: Surgical Wound Infection


subject: CHEBI:25681

object_name: phagocyte bactericidal dysfunction


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Stage IV Uveal Melanoma AJCC v7


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: sleep apnea


subject: UNII:MH5DMF9JKY

subject_name: Emavusertib

object_name: acute myeloid leukemia


subject: UNII:MH5DMF9JKY

object_name: Myelodysplasia


subject: UNII:MH5DMF9JKY

object_name: Adult Myelodysplastic Syndrome


subject: UNII:MH5DMF9JKY

object_name: childhood myelodysplastic syndrome


subject: UNII:MH5DMF9JKY

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:118224238


subject: PUBCHEM.COMPOUND:118224238


subject: PUBCHEM.COMPOUND:118224238


subject: PUBCHEM.COMPOUND:118224238


subject: PUBCHEM.COMPOUND:118224238


subject: UNII:0C1JUU9S0L

object_name: Adult Giant Cell Glioblastoma


subject: UNII:0C1JUU9S0L

object_name: Childhood Giant Cell Glioblastoma


subject: UNII:0C1JUU9S0L

object_name: giant cell glioblastoma


subject: UNII:0C1JUU9S0L

object_name: glioblastoma


subject: UNII:0C1JUU9S0L

object_name: Brain Stem Glioblastoma


subject: UNII:0C1JUU9S0L

object_name: glioma susceptibility 1


subject: UNII:0C1JUU9S0L

object_name: oligodendroglioma


subject: UNII:0C1JUU9S0L

object_name: glioma


subject: UNII:0C1JUU9S0L

object_name: malignant glioma


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: inflammatory bowel disease 1


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: cancer


subject: MESH:D000086663

object_name: neoplasm


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: UMLS:C5400806


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: Central retinal vein occlusion - non-ischemic


subject: UMLS:C4507843


subject: UMLS:C5963447

subject_name: CDC7 Inhibitor

object_name: refractory hematologic cancer


subject: PUBCHEM.COMPOUND:136662662


subject: PUBCHEM.COMPOUND:136662663


subject: CHEBI:27470

subject_name: Folic acid

object_name: colon carcinoma


subject: CHEBI:27470

object_name: colon cancer


subject: CHEBI:27470

object_name: adenoma


subject: CHEBI:27470

object_name: polyp of colon


subject: CHEBI:27470

object_name: Encounter due to family history of colonic polyps


subject: CHEBI:4315

subject_name: Danazol

object_name: Unexplained infertility


subject: UMLS:C0059403

subject_name: EO 9

object_name: bladder tumor


subject: UMLS:C0059403

object_name: urinary bladder carcinoma


subject: UMLS:C0059403

object_name: urinary bladder cancer


subject: UMLS:C0059403

object_name: childhood bladder carcinoma


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: CHEBI:17650

object_name: vitiligo


subject: UNII:IK51552IFH

subject_name: Zytron

object_name: Hypoestrogenism


subject: UNII:IK51552IFH

object_name: Bone Demineralization, Pathologic


subject: UNII:P8CL89W8AP


subject: UNII:P8CL89W8AP


subject: CHEBI:229727

subject_name: DMPA zwitterion


subject: CHEBI:229727


subject: CHEBI:6715

subject_name: medroxyprogesterone


subject: CHEBI:6715


subject: CHEBI:173106

subject_name: ferroptocide


subject: CHEBI:173106


subject: CHEBI:31536

subject_name: Emtricitabine


subject: CHEBI:31536


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63717


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:63625


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: UniProtKB:P36394


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: PR:000015643


subject: UMLS:C5446554

object_name: melanoma


subject: CHEBI:184023

subject_name: Argininosuccinic acid

object_name: Device related thrombosis


subject: CHEBI:135207

subject_name: Clofedanol


subject: CHEBI:15365

subject_name: Aspirin


subject: PR:000004321

subject_name: arylsulfatase A


subject: CHEBI:37941

subject_name: Clopidogrel


subject: CHEBI:45783

subject_name: Imatinib

object_name: chronic eosinophilic leukemia


subject: UMLS:C0759338

object_name: colorectal cancer


subject: UMLS:C0759338

object_name: colorectal carcinoma


subject: UMLS:C0759338

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C0759338

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C0759338

object_name: Embolism, Tumor


subject: UMLS:C0759338

object_name: Neoplasm Metastasis


subject: CHEBI:47097

subject_name: Lonafarnib


subject: CHEBI:47097


subject: CHEBI:47097


subject: CHEBI:47097


subject: CHEBI:47097


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: familial hyperlipidemia


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: gestational diabetes


subject: CHEBI:133021

subject_name: Venetoclax

object_name: acute promyelocytic leukemia


subject: UMLS:C0731177

subject_name: Madopar 125

object_name: Parkinson disease


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: colon carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: colon cancer


subject: UNII:980M4N37DH

object_name: cancer


subject: UNII:980M4N37DH

object_name: neoplasm


subject: UNII:980M4N37DH

object_name: ovarian cancer


subject: UNII:980M4N37DH

object_name: ovarian neoplasm


subject: UNII:980M4N37DH

object_name: ovarian carcinoma


subject: UNII:980M4N37DH


subject: UNII:980M4N37DH

object_name: colorectal cancer


subject: UNII:980M4N37DH


subject: UMLS:C2830086


subject: UMLS:C2830086


subject: UMLS:C2830086


subject: UMLS:C2830086


subject: UMLS:C2830086


subject: UMLS:C2830086


subject: UMLS:C2830086


subject: UMLS:C2830086


subject: UMLS:C0770612

subject_name: licorice root extract

object_name: arteriosclerosis disorder


subject: UMLS:C0770612

object_name: atherosclerosis


subject: UMLS:C0770612

object_name: diabetes mellitus


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: Diabetes


subject: UNII:71M78END5S


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:10782

subject_name: Perilla alcohol

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:10782

object_name: adult lymphoma


subject: CHEBI:10782

object_name: lymphoma


subject: CHEBI:10782

object_name: pediatric lymphoma


subject: CHEBI:145806

subject_name: (R)-(+)-perillyl alcohol


subject: CHEBI:145806


subject: CHEBI:145806


subject: CHEBI:145806


subject: CHEBI:15420

subject_name: perillyl alcohol


subject: CHEBI:15420


subject: CHEBI:15420


subject: CHEBI:15420


subject: CHEBI:32588

subject_name: Potassium chloride

object_name: Heart failure with normal ejection fraction


subject: CHEBI:63043


subject: CHEBI:7773

subject_name: Ondansetron

object_name: bipolar disorder


subject: CHEBI:7773

object_name: Mentally ill chemical abuse


subject: CHEBI:7773

object_name: Dual diagnosis (psychiatry)


subject: CHEBI:6801

subject_name: Metformin

object_name: mild neurocognitive disorder


subject: CHEBI:6801

object_name: mild cognitive impairment


subject: CHEBI:50217

subject_name: selegiline

object_name: cocaine abuse


subject: CHEBI:71196

subject_name: glucagon-like peptide-1 receptor agonist

object_name: Bowel incontinence


subject: CHEBI:71196

object_name: Fecal Incontinence, CTCAE


subject: CHEBI:71196

object_name: Weight loss


subject: CHEBI:71196

object_name: Weight Loss, CTCAE


subject: CHEBI:71196

object_name: urgency urinary incontinence


subject: CHEBI:71196

object_name: Stress urinary incontinence


subject: CHEBI:71196

object_name: pelvic organ prolapse


subject: CHEBI:71196

object_name: lower urinary tract symptom


subject: CHEBI:71196

object_name: Urinary Urgency


subject: UMLS:C2917359

subject_name: GLP-1 Receptor Agonist [EPC]


subject: UMLS:C2917359


subject: UMLS:C2917359


subject: UMLS:C2917359


subject: UMLS:C2917359


subject: UMLS:C2917359


subject: UMLS:C2917359


subject: UMLS:C2917359


subject: UMLS:C2917359


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Treatment related secondary malignancy


subject: UMLS:C3896806


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:157844

subject_name: Glu-Arg

object_name: Growth & development aspects


subject: CHEBI:157844

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:157844


subject: CHEBI:33379

subject_name: erbium


subject: CHEBI:33379


subject: CHEBI:33379


subject: UMLS:C5441529

subject_name: Estrogen Receptor Family, human


subject: UMLS:C5441529


subject: UMLS:C5441529


subject: PR:000007204

subject_name: estrogen receptor


subject: PR:000007204


subject: PR:000007204


subject: CHEBI:90943

subject_name: Osimertinib

object_name: progression free survival


subject: CHEBI:134709

subject_name: Pitolisant

object_name: Prader-Willi syndrome


subject: UMLS:C5447411

object_name: plasma cell myeloma


subject: CHEBI:9168

subject_name: Sirolimus

object_name: hypoglycemia


subject: CHEBI:9168

object_name: Blood glucose below reference range (finding)


subject: CHEBI:9168

object_name: Hypoglycemia, CTCAE


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: GTOPDB:8313

subject_name: talazoparib

object_name: Recurrent Endometrial Cancer


subject: GTOPDB:8313

object_name: Vaginal cancer recurrent


subject: GTOPDB:8313

object_name: Cervix carcinoma recurrent


subject: GTOPDB:8313

object_name: Recurrent Fallopian Tube Carcinoma


subject: GTOPDB:8313

object_name: Recurrent Primary Peritoneal Carcinoma


subject: GTOPDB:8313

object_name: Stage IVB Uterine Corpus Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IVA Uterine Corpus Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IV Vaginal Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IVA Vaginal Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IVA Cervical Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IV Cervical Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IVB Vaginal Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IVB Cervical Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: GTOPDB:8313

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: GTOPDB:8313

object_name: female reproductive organ cancer


subject: UMLS:C0876768

subject_name: Vioxx

object_name: glioma


subject: UMLS:C0876768

object_name: malignant glioma


subject: UMLS:C0876768

object_name: brain cancer


subject: UMLS:C0876768

object_name: brain neoplasm


subject: CHEBI:8887

subject_name: Rofecoxib


subject: CHEBI:8887


subject: CHEBI:8887


subject: CHEBI:8887


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: stroke due to basilar artery occlusion


subject: PUBCHEM.COMPOUND:22976653

object_name: basilar artery occlusion


subject: PUBCHEM.COMPOUND:22976653

object_name: Blood Clot


subject: PUBCHEM.COMPOUND:22976653

object_name: thrombosis


subject: PUBCHEM.COMPOUND:22976653

object_name: Thrombosis of blood vessel


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: UNII:1RXS4UE564


subject: UNII:1RXS4UE564


subject: UNII:1RXS4UE564


subject: UNII:1RXS4UE564


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: PR:000012825


subject: PR:000012825


subject: PR:000012825


subject: PR:000012825


subject: UMLS:C4763757

subject_name: Erfonrilimab

object_name: Metastatic non-small cell lung cancer


subject: UNII:PW3Q92Z6A4

subject_name: Ningetinib


subject: UMLS:C1541350

subject_name: Falimarev

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: UMLS:C1541350

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C1541350

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C1541350

object_name: pancreatic acinar cell carcinoma


subject: UMLS:C1541350

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C1541349

subject_name: Inalimarev


subject: UMLS:C1541349


subject: UMLS:C1541349


subject: UMLS:C1541349


subject: UMLS:C1541349


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: complications of organ transplant stem cells


subject: CHEBI:8863

subject_name: Riluzole

object_name: Melanoma recurrent


subject: CHEBI:8863

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:8863

object_name: Stage III Cutaneous Melanoma AJCC v7


subject: CHEBI:8863

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:8863

object_name: Stage IIIA Cutaneous Melanoma AJCC v7


subject: CHEBI:8863

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: CHEBI:8863

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: CHEBI:8863

object_name: Refractory Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Kinetic tremor


subject: CHEBI:64356

subject_name: Pregabalin


subject: UNII:0TJ631J0KP

object_name: COPD, severe early onset


subject: UNII:0TJ631J0KP

object_name: chronic obstructive pulmonary disease


subject: UMLS:C0111046

subject_name: Creon

object_name: malnutrition


subject: PUBCHEM.COMPOUND:16170201

subject_name: TEICOPLANIN

object_name: Febrile Neutropenia


subject: PUBCHEM.COMPOUND:16170201

object_name: Febrile Neutropenia, CTCAE


subject: PUBCHEM.COMPOUND:16170201

object_name: Infection


subject: PUBCHEM.COMPOUND:16170201

object_name: infectious disease


subject: PUBCHEM.COMPOUND:16170201

object_name: Adverse Event Associated with Infection


subject: CHEBI:76842


subject: CHEBI:76842


subject: UMLS:C2698398

subject_name: BEMA Fentanyl

object_name: cancer


subject: UMLS:C2698398

object_name: neoplasm


subject: CHEBI:79042

subject_name: Tasimelteon

object_name: kidney failure


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Control of hip fracture risk


subject: CHEBI:68579

object_name: hip fracture


subject: CHEBI:135207

subject_name: Clofedanol


subject: CHEBI:135207


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:184023

subject_name: Argininosuccinic acid


subject: CHEBI:184023


subject: PR:000004321

subject_name: arylsulfatase A


subject: PR:000004321


subject: CHEBI:94534

subject_name: olanzapine

object_name: non-small cell lung carcinoma


subject: PR:000009732

object_name: Recurrent Malignant Glioma


subject: UMLS:C1434451

subject_name: UL83 protein, Human herpesvirus 5


subject: UniProtKB:Q64163

subject_name: TFDP2_MOUSE Transcription factor Dp-2 (sprot)


subject: PR:000016270

subject_name: transcription factor Dp-2


subject: MESH:C503781

object_name: prostate carcinoma


subject: MESH:C503781

object_name: prostate cancer


subject: CHEBI:63608

subject_name: Maraviroc

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:63608

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:63608

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: carcinoid tumor


subject: UNII:DPT0O3T46P

object_name: digestive system neuroendocrine neoplasm


subject: UNII:DPT0O3T46P

object_name: APUdoma